^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    ZNF385A overexpression

    i
    Other names: ZNF385A, Zinc Finger Protein 385A, ZFP385, ZNF385, Hematopoietic Zinc Finger Protein, Retinal Zinc Finger Protein, Zinc Finger Protein 385, DKFZp586G1122, Hzf, HZF, RZF
    Entrez ID:
    25946
    almost3years
    ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma. (PubMed, Int J Mol Sci)
    Finally, the knockdown of ZNF385A and ZNF346 was observed to negatively affect the proliferation and migration of HepG2 cells in vitro. In conclusion, ZNF385A and ZNF346 are promising candidate biomarkers for the diagnosis, prognosis, and response to immunotherapy in HCC, and this study may help to understand the tumor microenvironment (TME) of liver cancer, and to develop new therapeutic targets.
    Journal • IO biomarker
    |
    ZNF384 (Zinc Finger Protein 384)
    |
    ZNF385A overexpression